PEPTID-PAC1-ANTAGONISTEN
European patent · EP3630147 · In force
Register entry
- Publication number
- EP3630147
- Application number
- EP18733107
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jun 1, 2018
- Published
- Apr 8, 2020
- Granted
- Mar 25, 2026
- Protection ends at the latest
- May 31, 2038
- Next annual fee due
- Jun 30, 2027
- IPC classes
- A61K 38/00 (2006.01)
- Priority
- US 201762514440 P 02.06.2017
- PCT application
- PCT/US2018/035597 01.06.2018
- PCT publication
- WO2018/222991 06.12.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.06.2026 → 30.06.2027
Published in Swissreg on 01.07.2026
- Mar 25, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 25.03.2026
Parties
Inventor
CHEN, Irwin
Los Angeles California 90025, US
CHONG, Su
Oxnard California 93035, US
HARRINGTON, Essa Hu
Camarillo California 93012, US
HONG, Fang-Tsao
Thousand Oaks California 91360, US
LONG, Jason C.
Newbury Park California 91320, US
MIRANDA, Leslie P.
Thousand Oaks California 91362, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.